Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

537
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
537

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterizing the Role of Ophthalmologists in the Care of Patients With Suspected Giant Cell Arteritis at an Academic Medical Center.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2026
Same author

Compressive Optic Neuropathy Due to Dolichoectatic Ophthalmic Artery.

Neuro-ophthalmology (Aeolus Press)·2026
Same author

Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Consensus Statement by the North American Neuro-Ophthalmology Society and the American Academy of Ophthalmology.

Ophthalmology·2026
Same author

Diagnosis of High Intracranial Pressure by Non-Optic Nerve Retinal Image Features.

Translational vision science & technology·2026
Same author

The role of optical coherence tomography in the evaluation of para-chiasmal lesions: a systematic review and meta-analysis.

Frontiers in ophthalmology·2026
Same author

Visual Outcomes of Plasma Exchange for Acute Optic Neuritis: A Report by the American Academy of Ophthalmology.

Ophthalmology·2026
Same journal

Ocular Manifestations of Giant Cell Arteritis.

Advances in ophthalmology and optometry·2025
Same journal

Distinguishing Papilledema from Pseudopapilledema in Children.

Advances in ophthalmology and optometry·2024
Same journal

EVALUATION AND MANAGEMENT OF POST-OPERATIVE COMPLICATIONS FOLLOWING CATARACT EXTRACTION AND INTRAOCULAR LENS PLACEMENT.

Advances in ophthalmology and optometry·2024
Same journal

Punctate Inner Choroiditis.

Advances in ophthalmology and optometry·2024
Same journal

Neuro-Ophthalmic Complications of COVID-19 Infection and Vaccination.

Advances in ophthalmology and optometry·2023
Same journal

Coronavirus Disease 2019-Related Health Disparities in Ophthalmology with a Retrospective Analysis at a Large Academic Public Hospital.

Advances in ophthalmology and optometry·2022
See all related articles

Related Experiment Video

Updated: Mar 3, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.9K

Objective Measures of Visual Function in Papilledema.

Heather E Moss1

  • 1Department of Ophthalmology & Visual Sciences, Department of Neurology & Rehabilitation, University of Illinois at Chicago, Chicago, IL.

Advances in Ophthalmology and Optometry
|April 29, 2017
PubMed
Summary
This summary is machine-generated.

Objective visual function tests may offer a more reliable alternative to standard automated perimetry for assessing vision in papilledema patients. Further research is needed to establish these methods for clinical use.

Keywords:
electroretinogramoptic nervepapilledemaphotopic negative responsepupillary light responseretinal ganglion cellsvisual evoked potential

More Related Videos

Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing
06:25

Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing

Published on: February 23, 2024

1.2K
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.6K

Related Experiment Videos

Last Updated: Mar 3, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.9K
Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing
06:25

Author Spotlight: Assessment of Visual Acuity in Central Vision Loss Through Motion-Based Peripheral Vision Testing

Published on: February 23, 2024

1.2K
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.6K

Area of Science:

  • Ophthalmology
  • Neuro-ophthalmology
  • Visual electrophysiology

Background:

  • Papilledema management requires accurate visual function assessment.
  • Standard automated perimetry (SAP) is the current standard but is subjective and prone to errors.
  • Objective tests may provide more reliable visual function data.

Purpose of the Study:

  • To review evidence for objective visual function tests in papilledema.
  • To discuss the potential of these tests to replace or supplement SAP.
  • To identify future research needs for clinical implementation.

Main Methods:

  • Review of existing literature on objective visual function tests.
  • Analysis of studies evaluating visual evoked potential, pattern electroretinogram, photopic negative response, and pupillary light response in papilledema.
  • Discussion of clinical applicability and future research directions.

Main Results:

  • Objective tests like visual evoked potential and pattern electroretinogram show promise in assessing visual function in papilledema.
  • These methods may offer more reliable and reproducible results compared to subjective perimetry.
  • Evidence suggests potential for these tests to supplement or replace current subjective methods.

Conclusions:

  • Objective visual function tests are valuable tools for managing papilledema.
  • Further investigation is required to validate these tests for widespread clinical adoption.
  • Development of standardized protocols will enhance their utility in papilledema patient care.